** Shares of Syntara SNT.AX fall as much as 12.5% to A$0.028, their lowest level since November 12, 2025
** Stock's biggest intraday pct loss since August 11, 2025
** On track for second straight session of losses
** Drug developer says it would raise A$2 mln ($1.43 million) to fund further clinical trials, among others, through placement
** Offer price of A$0.027/share marks 15.6% discount to stock's last close on April 24; Trading halt announced on April 27
** Stock down 17.1% YTD
($1 = 1.3963 Australian dollars)
(Reporting by Aamir Sheik Khalid in Bengaluru)
((Aamir.SheikKhalid@thomsonreuters.com))